Indivior Pharmaceuticals INDV
NASDAQ INDV
$34.79 +0.02 (+0.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

Indivior Pharmaceuticals (INDV) Short term Debt (2023 - 2025)

Updated

Indivior Pharmaceuticals (INDV) recorded Short term Debt of $29 million in Q4 2025, up 61.1% from $18 million a year earlier and up 61.1% from the prior quarter.

Analysis

Indivior Pharmaceuticals (INDV) Short term Debt (2023 - 2025) Analysis & Trends

Starting with Q4 2023, Indivior Pharmaceuticals' Short term Debt history includes 6 quarters.

  • Across earlier years, Short term Debt came in at $18 million in FY2024 (+500.0%) and $3 million in FY2023.
  • Per Business Quant, the preceding three quarters came in at $18 million (Q3 2025), $18 million (Q2 2025) and $18 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Indivior Pharmaceuticals 4.13 Bn 3.10 Bn 294.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 29.00 Mn
Sep 30, 2025 18.00 Mn
Jun 30, 2025 18.00 Mn
Mar 31, 2025 18.00 Mn
Dec 31, 2024 18.00 Mn
Dec 31, 2023 3.00 Mn
API Access

Indivior Pharmaceuticals Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=INDV&period=max&api_key=YOUR_API_KEY